Bispecific antibodies (BsAb) can recognize two different antigenic epitopes. This feature of dual specificity opens up a broad range of applications, involving redirecting immune cells to tumor cells, blocking two distinct signaling pathways simultaneously, dual targeting of diverse disease mediators, and delivering useful loads to targeted sites.